Inhibition of influenza C viruses by human MxA protein

Virus Research

Volumn 67, Issue 2, 2000, Pages 179-188

  Marschall, Manfred ^a   Zach, Anke ^b   Hechtfischer, Anne ^c   Foerst, Gisela ^b   Meier Ewert, Herbert ^b   Haller, Otto ^c  

^a UNIVERSITY HOSPITAL ERLANGEN   (Germany)

^b Inst Med Mikrobiol Immunol H   (Germany)

^c UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Antiviral activity; Human MxA protein; Influenza C viruses

Indexed keywords

MYXOVIRUS RESISTANCE PROTEIN A; UNCLASSIFIED DRUG;

ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; FLUORESCENCE IN SITU HYBRIDIZATION; INFLUENZA VIRUS C; NONHUMAN; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VERO CELL; VIRUS INHIBITION; VIRUS REPLICATION;

ANIMALS; ANTIVIRAL AGENTS; BLOTTING, WESTERN; CELL LINE; CERCOPITHECUS AETHIOPS; CYTOPATHOGENIC EFFECT, VIRAL; GTP-BINDING PROTEINS; HEMAGGLUTINATION TESTS; HUMANS; IN SITU HYBRIDIZATION; INFLUENZAVIRUS C; PROTEINS; RECEPTORS, VIRUS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, VIRAL; VERO CELLS; VIRUS REPLICATION;

INFLUENZA C VIRUS;

EID: 0034120218     PISSN: 01681702     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-1702(00)00140-4     Document Type: Article

References (34)

1. Arnheiter H., Frese M., Kambadur R., Meier E., Haller O. Mx transgenic mice - animal models of health. Chisari F.V., Oldstone M.B.A. Current Topics in Microbiology and Immunology - Transgenic Animals of Human Viral and Immunological Disease. 206:1996;119-147 Springer-Verlag, Berlin.
2. Camilleri J.J., Maassab H.F. Characteristics of a persistent infection in Madin-Darby canine kidney cells with influenza C virus. Intervirology. 29:1988;178-184.
3. Chomczynski P., Sacchi N. Single step method of RNA isolation by acidic guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:1987;156-159.
4. Diaz M.O., Ziemin S., Le Beau M.M., Pitha P., Smith S.D., Chilcote R.R., Rowley J.D. Homozygous deletion of the α- and β-interferon genes in human leukemia and derived cell lines. Proc. Natl. Acad. Sci. USA. 85:1988;5259-5263.
5. Frese M., Kochs G., Meier-Dieter U., Siebler J., Haller O. Human MxA protein inhibits tick-borne Thogoto virus but not Dhori virus. J. Virol. 69:1995;3904-3909.
6. Frese M., Kochs G., Feldmann H., Hertkorn C., Haller O. Inhibition of Bunyaviruses, Phleboviruses, and Hantaviruses by human MxA protein. J. Virol. 70:1996;915-923.
7. Haller O., Frese M., Kochs G. Mx proteins: mediators of innate resistance to RNA viruses. Rev. Sci. Tech. Off. Int. Epiz. 17:1998;220-230.
8. Hechtfischer A., Marschall M., Helten A., Böswald C., Meier-Ewert H. A highly cytopathogenic influenza C virus variant induces apoptosis in cell culture. J. Gen. Virol. 78:1997;1327-1330.
9. Hechtfischer A., Meier-Ewert H., Marschall M. A persistent variant of influenza C virus fails to interact with actin filaments during viral assembly. Virus Res. 61:1999;113-124.
10. Hefti H.P., Frese M., Landis H., Di Paolo C., Aguzzi A., Haller O., Pavlovic J. Human MxA protein protects mice lacking a functional type I interferon system against La Crosse virus and other lethal viral infections. J. Virol. 73:1999;6984-6991.
11. Kanerva M., Melen K., Vaheri A., Julkunen I. Inhibition of Puumala and Tula Hantaviruses in Vero cells by MxA protein. Virology. 224:1996;55-62.
12. Kochs G., Trost M., Janzen C., Haller O. MxA GTPase: oligomerization and GTP-dependent interaction with viral RNP target structures. Methods Companion Methods Enzymol. 15:1998;255-263.
13. Kochs G., Haller O. GTP-bound human MxA protein interacts with the nucleocapsids of Thogoto virus (Orthomyxoviridae). J. Biol. Chem. 274:1999;4370-4376.
14. Kochs G., Haller O. Interferon-induced human MxA GTPase blocks nuclear import of Thogoto virus nucleocapsids. Proc. Natl. Acad. Sci. USA. 96:1999;2082-2086.
15. Landis H., Simon-Jödicke A., Klöti A., Di Paolo C., Schnorr J.-J., Schneider-Schaulies S., Hefti H.P., Pavlovic J. Human MxA protein confers resistance to Semliki Forest virus and inhibits the amplification of a Semliki Forest virus-based replicon in the absence of viral structural proteins. J. Virol. 72:1998;1516-1522.
16. Manuguerra J.C., Hannoun C., Nicolson C., Robertson J. Genic amplification of the entire coding region of the HEF RNA segment of influenza C virus. J. Virol. Methods. 41:1993;59-76.
17. Marschall M., Böswald C., Schuler A., Youzbashi E., Meier-Ewert H. Productive and non-productive phases during long-term persistence of influenza C virus. J. Gen. Virol. 74:1993;2019-2023.
18. Marschall M., Schuler A., Böswald C., Helten A., Hechtfischer A., Lapatschek M., Meier-Ewert H. Nucleotide-specific PCR for molecular virus typing. J. Virol. Methods. 52:1995;169-174.
19. Marschall M., Schuler A., Meier-Ewert H. Influenza C virus RNA is uniquely stabilized in a steady state during primary and secondary persistent infections. J. Gen. Virol. 77:1996;681-686.
20. Marschall M., Meier-Ewert H., Herrler G., Zimmer G., Maassab H.F. The cell receptor level is reduced during persistent infection with influenza C virus. Arch. Virol. 142:1997;1155-1164.
21. Marschall M., Helten A., Hechtfischer A., Zach A., Banaschewski C., Hell W., Meier-Ewert H. The ORF, regulated synthesis and persistence-specific variation of influenza C viral NS1 protein. Virology. 253:1999;208-218.
22. Pavlovic J., Haller O., Staeheli P. Human and mouse Mx proteins inhibit different steps of the influenza virus multiplication cycle. J. Virol. 66:1992;2564-2569.
23. Pavlovic J., Arzet H.A., Hefti H.P., Frese M., Rost D., Ernst B., Kolb E., Staeheli P., Haller O. Enhanced virus resistance of transgenic mice expressing the human MxA protein. J. Virol. 69:1995;4506-4510.
24. Richter M.F., Schwemmle M., Herrmann C., Wittinghofer A, Staeheli P. Interferon-induced MxA protein - GTP binding and GTP hydrolysis properties. J. Biol. Chem. 270:1995;13512-13517.
25. Schneider-Schaulies S., Schneider-Schaulies J., Schuster A., Bayer M., Pavlovic J., Ter Meulen V. Cell type-specific MxA-mediated inhibition of measles virus transcription in human brain cells. J. Virol. 68:1994;6910-6917.
26. Schumacher B., Staeheli P. Domains mediating intramolecular folding and oliomerization of MxA GTPase. J. Biol. Chem. 273:1998;28365-28370.
27. Schuster A., Johnston I.C.D., Das T., Banerjee A.K., Pavlovic J., Ter Meulen V., Schneider-Schaulies S. Expression of the human MxA protein is associated with hyperphosphorylation of VSV P protein in human neural cells. Virology. 220:1996;241-245.
28. Staeheli P., Haller O., Boll W., Lindenmann J., Weissmann C. Mx protein: constitutive expression in 3T3 cells transformed with cloned Mx cDNA confers selective resistance to influenza virus. Cell. 44:1986;147-158.
29. Staeheli P., Pavlovic J. Inhibition of vesicular stomatitis virus mRNA synthesis by human MxA protein. J. Virol. 65:1991;4498-4501.
30. Staeheli P., Pitossi F., Pavlovic J. Mx-proteins: GTPases with antiviral activity. Trends Cell. Biol. 3:1993;268-272.
31. Thimme R., Frese M., Kochs G., Haller O. Mx1 but not MxA confers resistance against tick-borne Dhori virus in mice. Virology. 211:1995;296-301.
32. Zach A., Marschall M., Meier-Ewert H. Influenza C virus persistence depends on exceptional steps in viral RNA synthesis and transport. Arch. Virol. 144:1999;463-478.
33. Zhao H., De B.P., Das T., Banerjee A.K. Inhibition of human parainfluenza virus 3 replication by interferon and human MxA. Virology. 220:1996;330-338.
34. Zürcher T., Pavlovic J., Staeheli P. Mechanism of human MxA protein action: variants with changed antiviral properties. EMBO J. 11:1992;1657-1661.